Lipocine (LPCN) Short-term Investments (2015 - 2025)

Lipocine (LPCN) has 11 years of Short-term Investments data on file, last reported at $9.7 million in Q4 2025.

• Quarterly Short-term Investments fell 36.97% year-over-year to $9.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.7 million (down 36.97% YoY) and the FY2025 annual result came in at $9.7 million, down 36.97% from the prior year.
• Short-term Investments retreated to $9.7 million in Q4 2025, from $11.2 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $41.7 million in Q4 2021 to a low of $9.7 million in Q4 2025.
• A 5-year average of $23.6 million and a median of $21.2 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2021 — Short-term Investments jumped 9159.59% — and 2023, when it sank 41.24%.
• Tracing LPCN's Short-term Investments over 5 years: stood at $41.7 million in 2021, then dropped by 29.49% to $29.4 million in 2022, then slumped by 41.24% to $17.3 million in 2023, then retreated by 10.64% to $15.4 million in 2024, then tumbled by 36.97% to $9.7 million in 2025.
• The last three Short-term Investments figures came in at $9.7 million (Q4 2025), $11.2 million (Q3 2025), and $11.9 million (Q2 2025), per Business Quant data.